Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
Open Access
Abstract
Texture analysis provides image parameters from F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT). Although some parameters are associated with tumor biology and clinical features, the types and implications of these parameters are complicated. We applied pseudotime analysis, which has recently been used to estimate changes in individual sample characteristics, to texture parameters from FDG PET/CT images of locally advanced non-small-cell lung cancer (NSCLC) patients undergoing neoadjuvant concurrent chemoradiation therapy (CCRT) followed by surgery. Our subjects were 303 NSCLC patients who underwent pretherapeutic FDG PET/CT and tri-modality therapy. Texture parameters of the primary tumor were calculated from FDG PET/CT images acquired before neoadjuvant CCRT. Pseudotime analysis was performed using the PhenoPath tool. Clinicopathologic features including survival data were collected and survival analysis was performed to compare the prognostic significances of pseudotime parameters with those of conventional PET parameters. Pseudotime was successfully estimated from texture parameters. Normalized co-occurrence homogeneity, normalized co-occurrence inverse difference moment, and black–white symmetry showed positive correlations with pseudotime, short run emphasis, normalized co-occurrence dissimilarity, and short zone emphasis negative correlation. The maximum standardized uptake value (SUV) and mean SUV were not associated with overall survival. Pseudotime, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) showed significant associations with overall survival. In contrast to MTV and TLG, pseudotime was an independent prognostic factor for overall survival. Various metabolic texture parameters can be integrated into a single parameter using pseudotime analysis. Pseudotime of the primary tumor, estimated from FDG PET/CT images, better predicts overall survival in locally advanced NSCLC patients treated with tri-modality therapy than conventional PET parameters.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1A2C1092807)
- Future Medicine 20*30 Project of the Samsung Medical Center (#SMO1220071)
This publication has 25 references indexed in Scilit:
- FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Defining cell types and states with single-cell genomicsGenome Research, 2015
- Development and Evaluation of an Open-Source Software Package “CGITA” for Quantifying Tumor Heterogeneity with Molecular ImagesBioMed Research International, 2014
- Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Volume-Based Parameters of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Improve Outcome Prediction in Early-Stage Non–Small Cell Lung Cancer After Surgical ResectionAnnals of Surgery, 2013
- Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?Journal of Nuclear Medicine, 2012
- Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parametersActa Oncologica, 2010
- The clinical impact of integrated FDG PET–CT on management decisions in patients with lung cancerLung Cancer, 2009
- The Maximum Standardized Uptake Values on Integrated FDG-PET/CT Is Useful in Differentiating Benign From Malignant Pulmonary NodulesThe Annals of Thoracic Surgery, 2006
- Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancerEuropean Journal of Cancer, 2005